Michael Favet - 21 Feb 2023 Form 4 Insider Report for NeuroPace Inc (NPCE)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: NPCE
Reported as of: 21 Feb 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Feb 2023, 18:38:27 UTC
Prior SEC filing: 08 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Irina Ridley, Attorney-In-Fact

Key filing fact

Michael Favet filed Form 4 for NeuroPace Inc (NPCE) on 22 Feb 2023.

Key facts

This page summarizes Michael Favet's Form 4 filing for NeuroPace Inc (NPCE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Feb 2023, 18:38.

Change

Previous filing in this sequence was filed on 08 Mar 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NPCE transaction

Common Stock

Award

Transaction value: $0
Shares: +225,000
Change %: +124%
Price: $0.000000
Shares after: 407,080
Date: 21 Feb 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on February 21, 2024 and the remaining RSUs vest in eight (8) equal quarterly installments thereafter.